Bureau Veritas SABVI
▲ PositiveCapitalrelevance
DCF analysis suggests 23% upside, indicating undervaluation.
Impact on stocks 1
Industrials
Bureau Veritas SABureau Veritas DCF Shows 23% Upside Despite Mixed Valuation Signals
Analyst
A Discounted Cash Flow analysis suggests Bureau Veritas shares are undervalued by about 23.1% relative to an estimated intrinsic value of €35.97 per share, even as earnings-based metrics paint a more neutral picture. The DCF model, which uses last twelve month free cash flow of roughly €834 million and assumes continued growth, points to a meaningful discount from the current share price. However, the stock trades on a price-to-earnings multiple of about 24.4x, close to a modeled fair P/E of around 23.2x, indicating it is roughly fairly valued on that measure. The company’s LEAP 28 plan, which involves rotating the portfolio toward higher-margin activities and away from areas like Oil & Petrochemicals testing, is cited as a reason the DCF implies more value than the market is pricing in. The key question is whether Bureau Veritas can deliver the cash flows and portfolio shift embedded in that plan, or whether the current discount reflects execution risk rather than a clear opportunity.
Bureau Veritas SADCF analysis suggests 23% upside, indicating undervaluation.